Downstream characterization of anti-TNF-α single chain variable fragment antibodies

Human Antibodies

Volumn 21, Issue 1-2, 2012, Pages 41-48

  Abdolalizadeh, Jalal ^b,c,d   Nouri, Mohammad ^c   Zolbanin, Jafar Majidi ^d,e   Baradaran, Behzad ^e   Barzegari, Abolfazl ^b   Omidi, Yadollah ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Human TNF ; monoclonal antibody; phage display; protein purification

Indexed keywords

PROTEIN A; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AFFINITY CHROMATOGRAPHY; ANTIBODY DETECTION; ARTICLE; B LYMPHOBLAST; CONTROLLED STUDY; CYTOPLASM; DOWNSTREAM PROCESSING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; NONHUMAN; PHAGE DISPLAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICROSCOPY, FLUORESCENCE; PEPTIDE LIBRARY; SINGLE-CHAIN ANTIBODIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865504084     PISSN: 10932607     EISSN: 1875869X     Source Type: Journal    
DOI: 10.3233/HAB-2012-0260     Document Type: Article

References (37)

1. B.B. Aggarwal, L. Schwarz, M.E. Hogan and R.F. Rando, Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells, Cancer Res 56 (1996), 5156-5164.
2. A. as Cell, Purification of immunoglobulin G, Current Protocols in Cell Biology 16 (2000), 3.12.
3. B. Baradaran, A.Z. Hosseini, J. Majidi, S. Farajnia, J. Barar, Z.H. Saraf, J. Abdolalizadeh and Y. Omidi, Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice, Hum Antibodies 18 (2009), 11-16.
4. A. Boes, H. Spiegel, H. Delbruck, R. Fischer, S. Schillberg and M. Sack, Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco, Biotechnol Bioeng 108 (2011), 2804-2814.
5. H. Chang, W. Qin, Y. Li, J. Zhang, Z. Lin, M. Lv, Y. Sun, J. Feng and B. Shen, A novel human scFv fragment against TNF-alpha from de novo design method, Mol Immunol 44 (2007), 3789-3796.
6. W.C.S. Cho, Proteomic approaches to cancer target identification, Drug Discov Today Ther Strateg 4 (2007), 245-250.
7. P. Cutler, Affinity chromatography, in: Protein Purification Protocols, S. Doonan, ed., Human Press, Totowa, 1996, pp. 157-168.
8. G. D'Haens, K. Geboes, M. Noman, L. Lemmens and P. Rugeerts, Etanercept (TNF receptor fusion protein, enbrelR) is effective and well tolerated in active refractory Crohn's disease: Results of a single center pilot trial, Digest Liver Dis 32 (2000), A42.
9. D. Dimitrova, V. Choudhry, and C.C. Broder, Antibody fragment expression and purification, Methods Mol Biol 525 (2009), 491-498, xiii.
10. S. Dubel, Recombinant therapeutic antibodies, Appl Microbiol Biotechnol 74 (2007), 723-729.
11. T. Gura, Therapeutic antibodies: Magic bullets hit the target, Nature 417 (2002), 584-586.
12. D.Hof, S. Cooksley-Decasper, S. Moergeli andA. vonEckardstein, Generation of novel recombinant antibodies against nitrotyrosine by antibody phage display, Hum Antibodies 20 (2011), 15-27.
13. P. Holliger and P.J. Hudson, Engineered antibody fragments and the rise of single domains, Nat Biotech 23 (2005), 1126-1136.
14. H.R. Hoogenboom and G. Winter, By-passing immunisation: Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro, J Mol Biol 227 (1992), 381-388.
15. B. Jansson, M. Uhlen, and P.A. Nygren, All individual domains of staphylococcal protein A show Fab binding, FEMS Immunol Med Microbiol 20 (1998), 69-78.
16. S. Katoh, M. Imada, N. Takeda, T. Katsuda, H. Miyahara, M. Inoue and S. Nakamura, Optimization of silica-based media for antibody purification by proteinAaffinity chromatography, Journal of Chromatography A 1161 (2007), 36-40.
17. J. Laroche-Traineau, G. Clofent-Sanchez and X. Santarelli, Three-step purification of bacterially expressed human singlechain Fv antibodies for clinical applications, J Chromatogr B Biomed Sci Appl 737 (2000), 107-117.
18. C.M.Y. Lee, N. Iorno, F. Sierro and D. Christ, Selection of human antibody fragments by phage display, Nat Protocols 2 (2007), 3001-3008.
19. M. Liu, X. Wang, C. Yin, Z. Zhang, Q. Lin, Y. Zhen and H. Huang, A novel bivalent single-chain variable fragment (scFV) inhibits the action of tumour necrosis factor alpha, Biotechnol Appl Biochem 50 (2008), 173-179.
20. R. Maini, E.W. St Clair, F. Breedveld, D. Furst, J. Kalden, M. Weisman, J. Smolen, P. Emery, G. Harriman, M. Feldmann and P. Lipsky, Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group, Lancet 354 (1999), 1932-1939.
21. J. Majidi, J. Barar, B. Baradaran, J. Abdolalizadeh and Y. Omidi, Target therapy of cancer: Implementation of monoclonal antibodies and nanobodies, Hum Antibodies 18 (2009), 81-100.
22. M.L. Moss, L. Sklair-Tavron and R. Nudelman, Drug insight: Tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis, Nature Clinical Practice Rheumatology 4 (2008), 300-309.
23. A. Mostafaie and J. Abdolalizadeh, Immunogens of Brucella abortus (S19) identified by two-dimensional gel electrophoresis and immunobloting, Iran J Med Sci 30 (2005), 10-15.
24. A.L. Nelson and J.M. Reichert, Development trends for therapeutic antibody fragments, Nat Biotech 27 (2009), 331-337.
25. Y. Omidi, Smart multifunctional theranostics: Simultaneous diagnosis and therapy of cancer, BioImpacts 1 (2011), 145- 147.
26. A. Pini and L. Bracci, Phage display of antibody fragments, Current Protein and Peptide Science 1 (2000), 155-169.
27. J.M. Reichert, Monoclonal antibodies in the clinic, Nat Biotechnol 19 (2001), 819-822.
28. J.F. Rippmann, M. Klein, C. Hoischen, B. Brocks, W.J. Rettig, J. Gumpert, K. Pfizenmaier, R. Mattes and D. Moosmayer, Procaryotic expression of single-chain variable-fragment (scFv) antibodies: Secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplasmic expression in Escherichia coli, Appl Environ Microbiol 64 (1998), 4862-4869.
29. A.C.A. Roque, C.S.O. Silva and M.A. Taipa, Affinity-based methodologies and ligands for antibody purification: Advances and perspectives, Journal of chromatography. A 1160 (2007), 44-55.
30. M. Silacci, S. Brack, G. Schirru, J. Marlind, A. Ettorre, A. Merlo, F. Viti and D. Neri, Design, construction, and characterization of a large synthetic human antibody phage display library, PROTEOMICS 5 (2005), 2340-2350.
31. S.R. Stevens, T.H. Chang, J.M. Weinberg and R. Buchholz, History of development of TNF inhibitors TNF-alpha Inhibitors, in: TNF-alpha Inhibitors, J.M. Weinberg and R. Buchholz, eds, Birkḧauser Verlag, Basel, 2006, pp. 9-22.
32. M. Strandh, H.S. Andersson and S. Ohlson, Weak affinity chromatography, Methods Mol Biol 147 (2000), 7-23.
33. H. Thie, T.Meyer, T. Schirrmann, M. Hust and S.Dubel, Phage display derived therapeutic antibodies, Curr Pharm Biotechnol 9 (2008), 439-446.
34. P. Thillaivinayagalingam, K. Reidy, A. Lindeberg and A.R. Newcombe, Alternative to Protein A Capture, BioProcess Int 10 (2012), 36-39.
35. M.R. Tohidkia, J. Barar, F. Asadi and Y. Omidi, Molecular considerations for development of phage antibody libraries, Journal of Drug Targeting 20 (2012), 195-208.
36. A. Villa, E. Trachsel, M. Kaspar, C. Schliemann, R. Sommavilla, J.N. Rybak, C. Rosli, L. Borsi and D. Neri, A highaffinity humanmonoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo, Int J Cancer 122 (2008), 2405-2413.
37. J.P. Xiong, S.L. Goodman and M.A. Arnaout, Purification, analysis, and crystal structure of integrins, Methods in enzymology 426 (2007), 307-336.